First, aging and insulin resistance lead to abnormal activation or suppression of key regulators, including FoxO3, MyoD, and muscle atrophy-specific ubiquitin ligases (e.g., Atrogin-1/MAFbx and MuRF1) (36, 37). This evidence concerns the gene FBXO32 and Insulin resistance.